United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - latanoprost - eye drops - 50microgram/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - latanoprost 0.05 mg/ml - eye drops, solution - 50 mcg/ml - active: latanoprost 0.05 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium chloride water for injection - indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product. teratogenic effects: pregnancy category c. reproduction studies have been performed in rats and rabbits. in rabbits, an incidence of 4 of 16 dams had no viable fetuses at a dose that was approximately 80 times the maximum human dose, and the highest nonembryocidal dose in rabbits was approximately 15 times the maximum human dose. there are no adequate and well-controlled studies in pregnant women. latanoprost ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. it is not known whether this drug or its metabolites are excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when latanoprost ophthalmic solution is administered to a nursing wom

Canada - English - Health Canada

hikma canada limited - latanoprost; timolol (timolol maleate) - solution - 50mcg; 5mg - latanoprost 50mcg; timolol (timolol maleate) 5mg - beta-adrenergic agents

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - latanoprost; timolol maleate -

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

flagship biotech international pvt ltd - latanoprost - latanoprost....0.005%p/v

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

n/a - latanoprost - latanoprost....0,05 mg

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - latanoprost - eye drops, solution - latanoprost 50 µg/ml - ophthalmologicals

United States - English - NLM (National Library of Medicine)

a-s medication solutions - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product. risk summary there are no adequate and well-controlled studies of latanoprost ophthalmic solution administration in pregnant women to inform drug-associated risks. in animal reproduction studies, intravenous (iv) administration of latanoprost to pregnant rabbits and rats throughout the period of organogenesis produced malformations, embryofetal lethality and spontaneous abortion at clinically relevant doses [see data ]. the background risk of major birth defects and miscarriage for the indicated population is unknown. however, the background risk in the u.s. general population of major birth defects is 2 to 4%, and of miscarriage is 15 to 20% of clinically recognized pregnancies. data animal data embryofetal studies were conducted in pre

Canada - English - Health Canada

teva canada limited - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs